Cite

    Rühle, A. et al. (2022). The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation. Clinical and translational radiation oncology. pp. 120-127. [Online].